Skip to main content

ABI Balks, and SurroMed Taps Callida to Share $7.6M Grant to Build HTP Genotyping System

NEW YORK, Oct. 1 - SurroMed and Callida Genomics will share a $7.6 million grant from the US government to develop a universal high-throughput genotyping system.


The partners said the money, awarded by the National Institute of Standards and Technology's Advanced Technology Program, will help them develop a system that can score more than 100,000 SNPs per patient using a solution-array approach.


Over the next three years, SurroMed, which will receive $4.4 million, will bring to the table its Nanobarcode particle technology. Hyseq subsidiary Callida, which will pocket $3.2 million, will amplify DNA and identify and read SNPs, the companies said. NIST awards require each company to match its portion.


A SurroMed spokesman said the award, in October 2001, was originally slated to go to his company and Applied Biosystems. But ABI balked out, leaving SurroMed scrambling for a new partner. "We identified Callida, and here we are," said the spokesman, August Moretti.


Click here for more information.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.